Code
3F022312
Duration
01 October 2012 → 30 September 2016
Funding
Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
Promotor
Fellow
Research disciplines
-
Medical and health sciences
- Pathophysiology
Keywords
phosphoproteome
signaling
RSV
Project description
Human RSV is the most common cause of lower respiratory tract infection in infants. There is no vaccine available against this virus. The aim is to characterize host-controlled signaling kinases that are used and activated by RSV. Those kinases can be targeted and serve as potential new anti-RSV drugs.